Guidelines for the treatment of self-limiting upper respiratory tract ailments

Pharmaceutical Journal

Volumn 260, Issue 6978, 1998, Pages 134-139

  Porteous, Terry ^a   Bond, Christine ^a   Duthie, Iain ^b   Matheson, Catriona ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTITUSSIVE AGENT; ASCORBIC ACID; BRONCHODILATING AGENT; DECONGESTIVE AGENT; EMOLLIENT AGENT; EXPECTORANT AGENT; NON PRESCRIPTION DRUG;

COMMON COLD; COUGHING; DISEASE DURATION; FLOW; HUMAN; PATIENT COUNSELING; PRACTICE GUIDELINE; REVIEW; SYMPTOM; UPPER RESPIRATORY TRACT INFECTION;

EID: 0032561961     PISSN: 00316873     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (7)

1. Gadomski A, Horton L. The need for rational therapeutics in the use of cough and cold medicine in infants. Pediatrics 1992; 89:774-6.
2. Kaliner M, Shelhamer J, Borson B, Nadel J, Patow C, Marom Z. Human respiratory mucus. Am Rev Resp Dis 1986;134:612-21.
3. Scottish Medicines Resource Centre. Acute otitis media. Medicines Resource October 1993, No 13.
4. Monto AS. The common cold - cold water on hot news. JAMA 1994;271:1122-4.
5. Hendeles L. Selecting a decongestant. Pharmacotherapy 1993;13: 129S-34S and 143S-6S.
6. Whiteside MW. A controlled study of benzydamine oral rinse in general practice. Curr Med Res Op 1982; 8: 188-90.
7. Hemila H. Vitamin C and the common cold. Br J Nutr 1992; 67:3-16.